At Sysmex Inostics, we are pioneers in liquid biopsy who are on a mission to defeat cancer. As innovators in cancer detection, we have a deep knowledge of circulating tumor DNA (ctDNA) dynamics. Sysmex Inostics' ultra-sensitive liquid biopsy solutions were designed to deliver exquisite ctDNA detection to answer the most important clinical questions, both in the patient care setting as well as in BioPharma clinical development.
Ultra-Sensitive NGS Liquid Biopsy
Cost-Effective Discovery
Benchmark-setting Liquid Biopsy Technology: OncoBEAM allows for the detection of important mutations from 0.02% to 0.04% allele frequency to ensure reliable molecular information.
Support for All Phases of Clinical Development: Sysmex Inostics specializes in purpose-designed, ultra-sensitive tests capable of detecting genetic alterations at very low mutant allele frequencies.
Information in accordance with Art. 13 GDPR: https://www.sysmex-inostics.com/data
Germany: Sysmex Inostics GmbH, Falkenried 88, D-20251 Hamburg, Germany. +49 40- 325907-0
United States: Sysmex Inostics, Inc., 1812 Ashland Ave Suite 500, Baltimore, Maryland 21205, USA. +1-855-BEAM-DNA (232-6362)
Japan: Sysmex Corporation, 1-5-1 Wakinohama-Kaigandori, Chuo-ku, Kobe 651-0073, Japan. +81 78 265-0500